Filing Flows

Filing Flows › Health Care › Fitlife Brands (FTLF)

Fitlife Brands (FTLF) earnings and revenue breakdown

Latest: Q2 2026 · 10-Q filed Aug 13, 2026 · Fitlife Brands (FTLF) Q2 2026 earnings results →

Q2 2026 Revenue up 65% year over year to $26.5M · 7¢ of every $1 of revenue kept as net profit · operating margin 12.6%

Fitlife Brands made $26.5M in Q2 2026 (+65% Y/Y): Irwin $14.1M, Legacy FitLife $12.4M. Operating margin 12.6%, net earnings $1.9M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 13, 2026.

Revenue$26.5M
Year over year+65%
Operating margin12.6%
Net earnings$1.9M
Operating cash flow$3.6M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $26.5M in Q2 2026, up 65% year over year and up 5% from the previous quarter. Irwin was the largest line at 53% of revenue.

Gross margin was 37.0%, down 5.9 points from Q2 2025. Operating profit was $3.4M, a 12.6% margin (down 3.0 points year over year). Of the extra revenue versus Q2 2025, 8% reached operating profit, below the 16% margin then. Operating expenses grew 47% against revenue growth of 65%. The fastest-growing cost line was SG&A (+91%). Net earnings were $1.9M, up 12% year over year. The effective tax rate was 27.3%.

Operating cash flow was $3.6M (up 204% year over year), 186% of net earnings. Non-cash charges added back $252K of depreciation and amortization. Working capital and other items added $1.4M.

Quarterly history

Fitlife Brands revenue by quarterFitlife Brands revenue by quarter$15.0MQ4 2024$15.9MQ1 2025$16.1MQ2 2025$23.5MQ3 2025$25.9MQ4 2025$25.3MQ1 2026$26.5MQ2 2026
Fitlife Brands net earnings by quarterFitlife Brands net earnings by quarter$2.1MQ4 2024$2.0MQ1 2025$1.7MQ2 2025$921KQ3 2025$1.6MQ4 2025$1.7MQ1 2026$1.9MQ2 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q2 202610-QAug 13, 2026$26.5M+65%12.6%$1.9M$3.6M
Q1 202610-QMay 14, 2026$25.3M+59%12.1%$1.7M$2.5M
Q4 202510-KMar 31, 2026$25.9M+73%8.8%$1.6M$244K
Q3 202510-QNov 13, 2025$23.5M+47%9.9%$921K$3.7M
Q2 202510-QAug 14, 2025$16.1M-5%15.6%$1.7M$1.2M
Q1 202510-QMay 15, 2025$15.9M-4%18.6%$2.0M$2.3M
Q4 202410-KMar 27, 2025$15.0M+13%19.2%$2.1M$957K

Charts

Fitlife Brands: revenue growth, year over year and quarter over quarterFitlife Brands: revenue growth, year over year and quarter over quarterY/YQ/Q+13%Q4 2024-4%+6%Q1 2025-5%+1%Q2 2025+47%+46%Q3 2025+73%+10%Q4 2025+59%-2%Q1 2026+65%+5%Q2 2026
Latest (Q2 2026): Y/Y +65%, Q/Q +5%.
Fitlife Brands: where the cash came from (+) and went (−), TTM to Q2 2026Fitlife Brands: where the cash came from (+) and went (−), TTM to Q2 2026Other investing−$37.5MOther financing$16.0MNet borrowing (+) / repaid (−)$11.0MOperating cash flow$10.0MCash drawn (+) / kept (−)$496KExchange rates−$25KCapital spending−$13K
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Fitlife Brands: profit against cash, quarter by quarterFitlife Brands: profit against cash, quarter by quarterNet incomeOperating cash flow$2.1M$2.0MQ3 2024$2.1M$957KQ4 2024$2.0M$2.3MQ1 2025$1.7M$1.2MQ2 2025$921K$3.7MQ3 2025−$2.7M$244KQ4 2025$1.7M$2.5MQ1 2026$1.9M$3.6MQ2 2026
Latest (Q2 2026): Net income $1.9M, Operating cash flow $3.6M.
Fitlife Brands: diluted shares by fiscal year (split-adjusted)Fitlife Brands: diluted shares by fiscal year (split-adjusted)5MFY20205MFY20210MFY202210MFY202310MFY202410MFY2025
+118.2% since FY2020: more shares outstanding (issuance, stock pay); earlier years scaled for the 4-for-1 split before FY2021.
Fitlife Brands: long-term debt falling due (FY2024)Fitlife Brands: long-term debt falling due (FY2024)$3.4M2025$4.5M2026$2.6M2027$1.5M2028
Cash $4.5M, short-term investments —, long-term debt $13.1M at 2024-12-31.
Fitlife Brands in its industry: growth against margin (22 companies, SIC 2833)Fitlife Brands in its industry: growth against margin (22 companies, SIC 2833)revenue growth, year over year →↑ operating marginmedian +6%median -6%CURLFTLRYTRLVUSNAAAWHCRONCGCJUSHBTMDMRMDNAIINAGEMTEXLEEEFCHUCHYEXMEHACBDYADIANPHCCFOOFTLF (+65%, 13%)
Medicinal Chemicals & Botanical Products; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About Fitlife Brands

FitLife Brands, Inc. (the “ Company ”) is a provider of innovative and proprietary nutritional supplements and wellness products for health-conscious consumers marketed under the following brand names: (i) NDS Nutrition, PMD Sports, SirenLabs, Core Active, Nutrology, and Metis Nutrition (together, the “ NDS Products ”); (ii) iSatori, BioGenetic Laboratories, and Energize (together, the " iSatori Products "); (iii) Dr. Tobias, All Natural Advice, and Maritime Naturals (together, the “ MRC Products "); (iv) MusclePharm; and (v) Irwin Naturals, Applied Nutrition, and Nature’s Secret (together, the “ Irwin Products ”).

In its own words, from its 10-K, filed Mar 31, 2026.

Fitlife Brands against its Medicinal Chemicals & Botanical Products peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +65% against the peers' median +11%. Operating margin: 12.6% against the peers' median 4.2%.

CompanyQuarterRevenueY/YOp. margin
FTLF Fitlife BrandsQ2 2026$26.5M+65%12.6%
CURLF Curaleaf HoldingsQ3 2026$353M+11%0.8%
TLRY Tilray BrandsQ1 FY27$257M+23%-9.4%
TRLV Trulieve CannabisQ3 2026$230M-20%18.5%
USNA Usana Health SciencesQ2 2026$223M-5%-9.0%
AAWH Ascend Wellness HoldingsQ2 2026$126M-0.9%4.2%
CRON Cronos GroupQ3 2026$83.9M+72%10.8%
CGC Canopy GrowthQ2 FY27$71.1M+20%-23.1%
JUSH Jushi HoldingsQ3 2026$70.5M+7%5.0%

Source: Fitlife Brands 10-Q on SEC EDGAR · CIK 1374328 · Medicinal Chemicals & Botanical Products

13F: who owns FTLF and who is buying

Largest holders of FTLF (13F)Largest holders of FTLF (13F)Vanguard Group$3.3MVanguard Capital Management LLC$1.7MHorizon Kinetics Asset Management…$1.6MGeode Capital Management, LLC$540KMink Brook Asset Management LLC$513KBlackRock$388KVanguard Fiduciary Trust$289KMillennium Management LLC$258KMariner, LLC$242KBard Associates$233K
Funds' net buying of FTLF by quarter (13F)Funds' net buying of FTLF by quarter (13F)$6.2M2025-03−$1.5M2025-06$596K2025-09$1.4M2025-12−$863K2026-03−$2.0M2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on FTLF

History

Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results

Compare FTLF with

中文版:Fitlife Brands(FTLF)财报

Español · Français